How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy? 記事 How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy? Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma's Almanac article about…Certara2025年3月28日
Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI Article Forbes: Adoption Of Model-Informed Drug Development Can Improve Pharma ROI Published: 2024年11月27日 Recent decades have seen continuing declines in pharmaceutical R&D productivity. Inflation…Certara2024年11月27日
How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product Article How Modeling Was Used to Support the FDA Approval of a Topical Generic Drug Product Establishing bioequivalence for topical drug products can be challenging and costly, often requiring extensive comparative…Certara2024年11月5日
Pharma Exec: MDMA Therapy for Mental Health Conditions Article Pharma Exec: MDMA Therapy for Mental Health Conditions Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…Certara2024年10月28日
Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities Article Industry Sense – Drug Repurposing Unlocking New Therapeutic Possibilities Panelists: Adekemi Taylor, PhD, VP, Quantitive Science Services at CertaraJoab Williamson, Director of Clinical Operations,…Certara2024年9月16日
Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report Article Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report Check out this article in Fierce Pharma to learn how Certara's US Market Access team…Certara2024年9月11日
FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies Article FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies Certara's Dr. Fran Brown, Senior Vice President of Drug Development Science, is quoted in this…Certara2024年8月26日
The Uncertain Path Forward for Psychedelic Medicine Article The Uncertain Path Forward for Psychedelic Medicine Certara's Dr. Fran Brown, Senior Vice President of Drug Development Science, is quoted in this…Certara2024年8月26日
Overcoming CMC Challenges in Cell and Gene Therapy: Part I Article Overcoming CMC Challenges in Cell and Gene Therapy: Part I In this Manufacturing Chemist article, Certara's Drs. Hien Anh Bruno and Deven Shah discuss the…Certara2024年8月23日
Certara’s AI Answer to Medical Writing Challenges in Pharma Article Certara’s AI Answer to Medical Writing Challenges in Pharma Medical writing is a complex and regulated process that requires compliance with guidelines from health…Certara2024年7月30日